A Cell Therapy Approach Based on iPSC-Derived Midbrain Organoids for the Restoration of Motor Function in a Parkinson’s Disease Mouse Model

By transplanting midbrain organoid cells into the striatum region of a 6-OHDA-lesioned Parkinson’s disease mouse model, researchers found that the transplanted cells survived and highly efficiently differentiated into dopaminergic neurons.